Destiny Pharma
      
Skip to content
  • About Us
    • Board of Directors
    • Leadership
    • Scientific Advisory Board
    • History
  • Pipeline
    • NTCD-M3 for Clostridioides difficile Infections
    • XF-73 Nasal for Post Surgical Infections
    • XF-73 for Dermal Infections
    • SPOR-COV™ for COVID-19
    • XF Research Programs
  • Target Markets
    • Clostridioides difficile Infections
    • Post Surgical Infections
    • Dermal Infections
    • COVID-19
    • Anti-Microbial Resistance
  • Our Technologies
    • Biotherapeutics
      • NTCD-M3
      • SPOR-COV™
    • XF Platform
  • Business Development
  • News and Media
    • Media Coverage
    • Events
  • Investors
    • AIM Rule 26
    • Corporate Governance
    • Share Price Information
    • Regulatory News
    • Constitutional Documents
    • Reports & Presentations
    • Advisers / Shareholder Contacts
    • Analyst Coverage
    • Email Alerts
    • FAQ
  • Contact
    • Careers
    • Useful Links

Uncategorised

Destiny Pharma to attend 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics, 12 – 13 March 2020, Basel, Switzerland

Posted on 22/01/2020 by Kirsty Richardson

Destiny Pharma is attending the 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics on 12 – 13 March 2020, in Basel, Switzerland

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Uncategorised

Destiny Pharma to attend Infection Control 2020, 13 February 2020, Birmingham, UK

Posted on 22/01/2020 by Kirsty Richardson

Destiny Pharma is attending the Infection Control 2020 conference on 13 February 2020, in Birmingham, UK

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Uncategorised

Destiny Pharma to present at LSX World Congress 2020, 4th February 2020, London, UK

Posted on 07/01/2020 by Kirsty Richardson

Destiny Pharma is presenting at the LSX World Congress 2020 on 4 February 2020, in London, UK

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Uncategorised

Destiny Pharma to present at JPM / Biotech Showcase 2020, 13 – 15 January 2020, San Francisco, USA

Posted on 29/11/2019 by Kirsty Richardson

Destiny Pharma is presenting JPM / Biotech Showcase 2020 on 13 – 15 January 2020, in San Francisco, USA

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Posted in Uncategorised

Share Price

Latest News

  • 29 Mar 2021 – Destiny Pharma to Join Equity Development Webinar 29/03/2021
  • 29 Mar 2021 – Destiny Pharma Phase 2b results – Analyst and Investor webcast and conference call details – Monday 29th March at 1100 BST 29/03/2021
  • 29 Mar 2021 – Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel 29/03/2021

Events

  • Destiny Pharma to present at Bio €quity Europe conference, 17 – 19 May 2021 22/03/2021
  • Destiny Pharma to present at the Pharmabiotics Conference, 28 – 29 April 2021 22/03/2021

Destiny Pharma

© All rights reserved.

Powered by WordPress

Destiny Pharma plc
Sussex Innovation Centre
Science Park Square
Brighton
BN1 9SB
UK

Tel: +44(0) 1273 704440

Registered Company
No. 3167025
About Us
Pipeline
Target Markets
Our Technologies
Business Development
News
Investors
Contact
Terms of Use
Privacy Statement